• The New Money
  • Posts
  • Elon's AI Venture Gets A Boost, Concealed Weapon Detection, and Cheaper Cultivated Meat

Elon's AI Venture Gets A Boost, Concealed Weapon Detection, and Cheaper Cultivated Meat

Uncovering the world’s most exciting early stage companies. Discover what’s next.

The Public Company Backing Elon Musk’s Artificial Intelligence Venture

HEALWELL AI (TSX: AIDX) has invested $2 million into Elon Musk’s artificial intelligence startup xAI. The new investment from HEALWELL AI into xAI will unlock access to xAI’s closed Developer Program which will give HEALWELL AI insight into the Large Language Models under development as well as xAI’s unique datasets.

The Startup Using Artificial Intelligence To Spot Concealed Weapons

ZeroEyes raised $53 million in a Series B financing round that saw participation from the venture capital arm of Intel. ZeroEyes has built proprietary artificial intelligence screening technology to rapidly detect weapons being concealed by human beings in public spaces.

Cutting Down The Cost Of Cultivated Meat

Ever After Foods has raised $10 million in a new financing round to advance their bioreactor platform that they claim is now the cheapest production method in the world for producing cultivated meat at scale - which has been one of the notable critiques around the nascent sector’s ability to replace factory farmed meat globally.

The Sprint

New here? Join our community of 25,000+ individuals interested in uncovering the world’s most exciting early stage companies.

Disclaimer: The New Money provides background information on early stage companies from publicly available sources. The New Money provides no advice on dealing in securities, is not a financial adviser and does not pretend to be so. This message is meant for information and educational purposes only. The information contained in this email is not to be considered factual or complete. Anybody interested in obtaining financial and other information on companies mentioned is advised to get it direct from the companies, or from their own investment adviser. The New Money does not intend for this information to be used to inform an investment decision. The New Money has been compensated by some of the companies mentioned in this email for awareness campaigns, which affects our ability to be unbiased. The Principals of The New Money may buy or sell shares of the mentioned companies without further notice. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities. The New Money and its principals and agents are not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Always do your own research and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment. Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy or Sell securities. No representation is being made that any stock trade will or is likely to achieve profits. Comparisons made to other featured companies or past performance is not indicative of future results.